A Comparison of CoolStick With Ethyl Chloride for the Assessment of Light Touch
Launched by BARTS & THE LONDON NHS TRUST · Sep 11, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two methods for checking how well patients can feel light touch and cold sensations after receiving anesthesia for a planned cesarean delivery. The study will evaluate a device called CoolStick against a spray called ethyl chloride, which is commonly used to numb the skin. It aims to see which method works better for assessing these sensations in women who are undergoing the procedure.
To participate in this trial, you need to be a pregnant woman scheduled for an elective cesarean section and planning to receive spinal or combined spinal-epidural anesthesia. Unfortunately, if you are under 18 years old, have allergies to stainless steel or ethyl chloride, or cannot give consent or understand English, you won't be eligible. If you join the study, you’ll be asked about any pain you might feel during the operation, and your experiences will help improve how doctors assess anesthesia in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant patients presenting for elective caesarean section under spinal or combined spinal-epidural anaesthesia.
- Exclusion Criteria:
- • \< 18 years old
- • Unwilling or unable to give informed consent
- • Inability to understand written and/or verbal English
- • Allergy to stainless steel
- • Allergy to ethyl chloride spray
About Barts & The London Nhs Trust
Barts and The London NHS Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality clinical care, research, and education. As a prominent sponsor of clinical trials, the Trust is dedicated to advancing medical knowledge and improving patient outcomes through innovative research initiatives. With a focus on patient safety and ethical standards, Barts and The London NHS Trust collaborates with multidisciplinary teams to explore cutting-edge therapies and interventions across various medical fields, ensuring that trial participants receive the highest level of care and support throughout their involvement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
London, , United Kingdom
London, , United Kingdom
Patients applied
Trial Officials
Matthew Wikner
Study Chair
Barts & The London NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported